Clinical trial
Study to Evaluate 3 Dosages of Estetrol After 28 Days Administration in Healthy…
NCT00163033 · Pantarhei Bioscience, Industry · Completed
Key facts
| NCT number | NCT00163033 |
|---|---|
| Title | Study to Evaluate 3 Dosages of Estetrol After 28 Days Administration in Healthy Postmenopausal Women |
| Official title | Phase I Study to Evaluate the Safety, Tolerability, PK and Pharmacodynamics of 3 Dosages of Estetrol, the Lowest Dose of 2 mg Estetrol Compared With 2 mg of E2, After Daily Oral Administration for 28 Days in Healthy Postmenopausal Women |
| Lead sponsor | Pantarhei Bioscience, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | estetrol |
| Enrollment | 49 |
| Start date | Jun 1, 2005 |
| Primary completion | Aug 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Sep 13, 2005 |
| Last update posted | May 21, 2012 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: